Table 3.
Diagnostic performance of serum fibroblast growth factor 19 Levels and other existing markers alone and in combination for differentiation of hepatocellular carcinoma
|
Cut-off value of FGF19
|
Biomarker
|
Sensitivity (%)
|
Specificity (%)
|
PPV (%)
|
NPV (%)
|
AUC value
|
| FGF19 cut-off value: 200 pg/mL[129] | FGF19 ≥ 200 pg/mL | 53.2 | 95.1 | 95.9 | 48.7 | 0.795 |
| FGF19 ≥ 200 pg/mL and AFP ≥ 20 ng/mL | 76.0 | 91.5 | 95.1 | 64.0 | ||
| FGF19 ≥ 200 pg/mL and DCP ≥ 40 mAU/mL | 81.3 | 91.0 | 95.4 | 68.8 | ||
| FGF19 ≥ 200 pg/mL and AFP ≥ 20 ng/mL, DCP ≥ 40 mAU/mL | 87.5 | 87.2 | 94.0 | 76.3 | ||
| FGF19 cut-off value: 180 pg/mL[130] | FGF19 > 180 pg/mL | 100 | 90 | 90 | 100 | 0.98 |
| FGF19 cut-off value: 140.8 pg/mL[131] | FGF19 ≥ 140.8 pg/mL | 81.8 | 87.9 | 87.1 | 82.9 | |
| FGF19 ≥ 140.8 pg/mL and AFP ≥ 13.1 ng/mL | 93.9 | 66.7 | 75.6 | 90.9 | ||
| FGF19 ≥ 140.8 pg/mL and DCP ≥ 0.725 ng/mL | 90.9 | 45.5 | 62.5 | 83.3 | ||
| FGF19 ≥ 140.8 pg/mL and AFP ≥ 13.1 ng/mL, DCP ≥ 0.725 ng/mL | 93.9 | 27.3 | 56.4 | 81.8 |
FGF19: Fibroblast growth factor-19; AFP: Alpha-fetoprotein; DCP: Des-γ-carboxy prothrombin; PPV: Positive predictive value; NPV: Negative predictive value; AUC: Area under the curve.